Brind.

Scripps Research and Dyadic International, Inc. are delivering antigens for preclinical evaluation of new vaccine candidates.

1 report, 1 independent Updated Jul 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Scripps Research and Dyadic International, Inc. are delivering antigens for preclinical evaluation of new vaccine candidates.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

  • Scripps Research

    nonprofit American medical research facility that focuses on research and education in the biomedical sciences

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • manilatimes.netDyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days